Search Result "EFV"
Correlation of CYP2B6-516G>T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand
Journal: Current HIV Research
Volume: 10 Issue: 8 Year: 2012 Page: 653-660
Author(s): Linda Aurpibul,Nuntisa Chotirosniramit,Patcharaphan Sugandhavesa,Natthapol Kosashunhanan,Sunida Thetket,Taweewat Supindham,Weerawit Piyamongkol,Khuanchai Supparatpinyo
Impact of Ritonavir, Atazanavir and Their Combination on the CYP3A4 Induction by Efavirenz in Primary Human Hepatocytes
Journal: Drug Metabolism Letters
Volume: 4 Issue: 1 Year: 2010 Page: 45-50
Author(s): Ganesh M. Mugundu, Niresh Hariparsad, Pankaj B. Desai
Differential Effects of Efavirenz and Lopinavir/Ritonavir on Human Adipocyte Differentiation, Gene Expression and Release of Adipokines and Pro-Inflammatory Cytokines.
Journal: Current HIV Research
Volume: 8 Issue: 7 Year: 2010 Page: 545-553
Author(s): Jose M. Gallego-Escuredo, M. del Mar Gutierrez, Julieta Diaz-Delfin, Joan C. Domingo, M. Gracia Mateo, Pere Domingo, Marta Giralt, Francesc Villarroya
Multiple-Dose Pharmacokinetics of Efavirenz with and without the Use of Rifampicin in HIV-Positive Patients
Journal: Current HIV Research
Volume: 5 Issue: 3 Year: 2007 Page: 349-353
Author(s): Alberto Matteelli, Mario Regazzi, Paola Villani, Giuseppina De Iaco, Maria Cusato, Anna Cristina C. Carvalho, Silvio Caligaris, Lina Tomasoni, Maria Manfrin, Susanna Capone, Giampiero Carosi
A Highly Concentrated and Taste-Improved Aqueous Formulation of Efavirenz for a More Appropriate Pediatric Management of the Anti-HIV Therapy
Journal: Current HIV Research
Volume: 8 Issue: 3 Year: 2010 Page: 223-231
Author(s): Diego A. Chiappetta, Christian Hocht, Alejandro Sosnik
Effects of Highly Active Antiretroviral Therapy on Albuminuria in HIV-infected Persons
Journal: Infectious Disorders - Drug Targets
Volume: 20 Issue: 3 Year: 2020 Page: 374-384
Author(s): Tewogbade Adeoye Adedeji,Simeon Adelani Adebisi,Nife Olamide Adedeji
Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1â Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE
Journal: Current HIV Research
Volume: 11 Issue: 7 Year: 2013 Page: 570-575
Author(s): Robert Ryan,Yaswant K. Dayaram,Deborah Schaible,Bruce Coate,David Anderson
Combination Therapy Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Associated with Hepatic Failure
Journal: Current Drug Safety
Volume: 7 Issue: 5 Year: 2012 Page: 391-393
Author(s): Sohail Qayyum,Huijun Dong,Dianne Kovacic,Sidra Sohail,Bradford Waters,Camille Thornton,Cathy E. Corbett
Simultaneous Estimation and Validation of Tenofovir Disoproxil Fumarate, Emtricitabine and Efavirenz by RP-HPLC Method in Combined tablet Dosage Form
Journal: Current Pharmaceutical Analysis
Volume: 15 Issue: 6 Year: 2019 Page: 561-567
Author(s): Mehdi Rezaei,Ali Ramazani,Fahimeh Hokmabadi
Impact of Lopinavir/Ritonavir and Efavirenz-Based Antiretroviral Therapy on the Lipid Profile of Chinese HIV/AIDS Treatment-Naïve Patients in Beijing: A Retrospective Study
Journal: Current HIV Research
Volume: 17 Issue: 5 Year: 2019 Page: 324-334
Author(s): Lili Dai,An Liu,Hongwei Zhang,Hao Wu,Tong Zhang,Bin Su,Ying Shao,Jianwei Li,Jiangzhu Ye,Sarah Robbins Scott,Supriya D. Mahajan,Stanley A Schwartz,Hongwei Yu,Lijun Sun